LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.04 | 21.74 | 7 | 750 | 0.0093 | -0.1989 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.04 | 21.74 | 1475 | 750 | 1.9652 | 1.2827 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.01 | 21.74 | 288 | 901 | 0.3193 | 0.6173 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.01 | 21.74 | 1327 | 901 | 1.4713 | 1.1490 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.01 | 21.74 | 2 | 901 | 0.0022 | -0.3585 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.01 | 21.74 | 1644 | 901 | 1.8228 | 1.2364 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.98 | 21.74 | 676 | 1108 | 0.6099 | 0.8330 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.98 | 21.74 | 1448 | 1108 | 1.3064 | 1.0965 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.98 | 21.74 | 2 | 1108 | 0.0018 | -0.3434 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.98 | 21.74 | 1779 | 1108 | 1.6051 | 1.1740 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.95 | 21.74 | 1090 | 1354 | 0.8047 | 0.9284 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.95 | 21.74 | 1564 | 1354 | 1.1546 | 1.0488 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.95 | 21.74 | 4 | 1354 | 0.0030 | -0.2472 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.95 | 21.74 | 1925 | 1354 | 1.4211 | 1.1215 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.92 | 21.74 | 1288 | 1515 | 0.8498 | 0.9475 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.92 | 21.74 | 1619 | 1515 | 1.0682 | 1.0217 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.92 | 21.74 | 20 | 1515 | 0.0132 | -0.0135 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.92 | 21.74 | 2055 | 1515 | 1.3559 | 1.1019 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.89 | 21.74 | 1456 | 1677 | 0.8682 | 0.9554 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.89 | 21.74 | 1739 | 1677 | 1.0370 | 1.0116 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.89 | 21.74 | 42 | 1677 | 0.0250 | 0.1108 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.89 | 21.74 | 2253 | 1677 | 1.3435 | 1.0964 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.86 | 21.74 | 1737 | 1887 | 0.9205 | 0.9744 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.86 | 21.74 | 1866 | 1887 | 0.9889 | 0.9965 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.86 | 21.74 | 11 | 1887 | 0.0058 | -0.1004 | MN20160310_N01 | K18 |